Brief: Qlife Receives Order From Statens Serum Institut For COVID-19 Testing
Jan 29 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE HOLDING AB: QLIFE RECEIVES ORDER FROM STATENS SERUM
INSTITUT FOR COVID-19 TESTING
* ORDER REPRESENTS A VALUE OF APPROXIMATELY 1 MDKK, AND
QLIFE
EXPECTS TO COMPLETE DELIVERY IN FEBRUARY 2021.
Source text: https://mfn.se/cis/a/qlife-holding/qlife-holding-ab-qlife-receives-order-from-statens-serum-institut-for-covid-19-testing-105d0a80
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million